HER-2 Negative Breast Cancer Market Expected to Witness High Growth...

heeft een bestand toegevoegd Health

2023-11-29 09:46:19 -

HER-2 Negative Breast Cancer Market Expected to Witness High Growth Owing to Increasing Prevalence of Breast Cancer

The HER-2 negative breast cancer market is estimated to be valued at US$ 13,873.7 Mn in 2023 and is expected to exhibit a CAGR of 10.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:HER-2 negative breast cancer accounts for around 70% of all breast cancer cases globally. It develops in breast cells that lack excess...

0 Reacties 0 aandelen 1410 Views 0 voorbeeld